Diagnostic Cytopathology · 2012 · 25 citations · 16 references
MedicineOncologyPathologyMetastasisMolecular OncologyNeoplasiaColorectal CancerLung CancerMalignant NeoplasmsMalignant TumorsMolecular Classification Of TumorsOncogene MutationsColorectal Cancer PathologyCytological DifferentiationEgfr Mutation TestingGastrointestinal CytologyKras Mutation AnalysisKras Mutation TestingNon-small Cell Lung Carcinoma Cytology
Epidermal growth factor receptor (EGFR) and Kras gene mutations are crucial for discriminating patients responsive to anti-EGFR drugs in non-small cell lung cancer (NSCLC) and colorectal cancer (CRC), respectively. The majority of NSCLCs come to clinical attention at an advanced stage when surgery is no longer recommended and a considerable number of them are diagnosed by cytology only. A large number of metastatic CRCs are also diagnosed by imaging and minimally invasive techniques such as fine-needle aspiration biopsy. Here, we report our experience in the mutation analysis of EGFR and Kras on cytological material obtained from superficial and deep lesions of NSCLC and CRC. Our series included 63 cytological specimens from primary or metastatic lesions of 42 NSCLCs and 21 CRCs. The cytological material was adequate for the mutation analysis in 39/42 (93%) NSCLCs and in 20/21(95%) CRCs. EGFR and Kras mutations were found in 9 (23%) and 9 (23%) NSCLC cases, respectively. Kras mutations were found in 9/20 (45%) CRC specimens. Histological samples from the primary tumors were available in 9/42 NSCLCs and in 17/21 CRCs. The agreement of EGFR and Kras mutational status in cytological vs. histological samples was 100% for NSCLC and 88% for CRC. Our results suggest that standard cytology provides adequate material for the assessment of EGFR and Kras mutational status in NSCLC and CRC patients and could be specifically indicated in patients not eligible for surgery but candidate to anti-EGFR therapy.
16
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
J. Guillermo Paez, Pasi A. Jänne, Jeffrey C. Lee et al. · Science · 2004 · 9.4K citations
William Pao, Vincent A. Miller, Maureen F. Zakowski et al. · Proceedings of the National Academy of Sciences · 2004 · 4.3K citations · Full text
Natasha Rekhtman, Suzanne M. Brandt, Carlie Sigel et al. · Journal of Thoracic Oncology · 2011 · 234 citations · Full text
<i>EGFR</i> and <i>KRAS</i> mutations in lung carcinoma
Shahreen Billah, John Stewart, Gregg Staerkel et al. · Cancer Cytopathology · 2011 · 226 citations · Full text